Statements of Stockholders' Equity (Deficit) - USD ($) | Common Stock | Additional Paid-In Capital | Deferred Stock-based Compensation | Accumulated Deficit | Total |
Beginning balance, shares at Dec. 31, 2017 | 25,515,000 | | | | |
Beginning balance, value at Dec. 31, 2017 | $ 2,552 | $ 254,948 | | $ (279,487) | $ (21,987) |
Common stock and warrants issued for cash, shares | | | | | |
Common stock and warrants issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | $ (18,020) | $ (18,020) |
Ending balance, shares at Mar. 31, 2018 | 25,151,000 | | | | |
Ending balance, value at Mar. 31, 2018 | $ 2,552 | $ 254,948 | | $ (297,507) | $ (40,007) |
Beginning balance, shares at Dec. 31, 2017 | 25,515,000 | | | | |
Beginning balance, value at Dec. 31, 2017 | $ 2,552 | $ 254,948 | | $ (279,487) | $ (21,987) |
Net loss | | | | | $ (4,635,716) |
Ending balance, shares at Dec. 31, 2018 | 36,303,800 | | | | |
Ending balance, value at Dec. 31, 2018 | $ 3,630 | $ 5,648,270 | $ (829,167) | $ (4,915,203) | $ (92,470) |
Beginning balance, shares at Mar. 31, 2018 | 25,151,000 | | | | |
Beginning balance, value at Mar. 31, 2018 | $ 2,552 | $ 254,948 | | $ (297,507) | $ (40,007) |
Common stock and warrants issued for cash, shares | | | | | |
Common stock and warrants issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | $ (29,089) | $ (29,089) |
Ending balance, shares at Jun. 30, 2018 | 25,515,000 | | | | |
Ending balance, value at Jun. 30, 2018 | $ 2,552 | $ 254,948 | | $ (326,596) | $ (69,096) |
Common stock and warrants issued for cash, shares | 63,800 | | | | |
Common stock and warrants issued for cash, value | $ 6 | $ 31,894 | $ (5,362,500) | | |
Expense recognition of deferred stock-based compensation | | | 1,958,334 | | |
Net loss | | | | $ (1,988,589) | $ (1,988,589) |
Ending balance, shares at Sep. 30, 2018 | 36,303,800 | | | | |
Ending balance, value at Sep. 30, 2018 | $ 3,630 | $ 5,648,270 | $ (3,404,166) | $ (2,315,185) | $ (67,451) |
Common stock and warrants issued for cash, shares | | | | | |
Common stock and warrants issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | 2,574,999 | | 2,574,999 |
Net loss | | | | $ (2,600,018) | $ (2,600,018) |
Ending balance, shares at Dec. 31, 2018 | 36,303,800 | | | | |
Ending balance, value at Dec. 31, 2018 | $ 3,630 | $ 5,648,270 | $ (829,167) | $ (4,915,203) | $ (92,470) |
Common stock and warrants issued for cash, shares | 200,000 | | | | |
Common stock and warrants issued for cash, value | $ 20 | $ 99,980 | | | $ 100,000 |
Expense recognition of deferred stock-based compensation | | | 829,167 | | 829,167 |
Net loss | | | | $ (876,661) | $ (876,661) |
Ending balance, shares at Mar. 31, 2019 | 36,503,800 | | | | |
Ending balance, value at Mar. 31, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,791,864) | $ (39,964) |
Beginning balance, shares at Dec. 31, 2018 | 36,303,800 | | | | |
Beginning balance, value at Dec. 31, 2018 | $ 3,630 | $ 5,648,270 | $ (829,167) | $ (4,915,203) | $ (92,470) |
Net loss | | | | | $ (947,319) |
Ending balance, shares at Dec. 31, 2019 | 36,503,800 | | | | |
Ending balance, value at Dec. 31, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,862,522) | $ (110,622) |
Beginning balance, shares at Mar. 31, 2019 | 36,503,800 | | | | |
Beginning balance, value at Mar. 31, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,791,864) | $ (39,964) |
Common stock and warrants issued for cash, shares | | | | | |
Common stock and warrants issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | (30,875) | (30,875) |
Ending balance, shares at Jun. 30, 2019 | 36,503,800 | | | | |
Ending balance, value at Jun. 30, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,822,739) | $ (70,839) |
Common stock and warrants issued for cash, shares | | | | | |
Common stock and warrants issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | $ (24,712) | $ (24,712) |
Ending balance, shares at Sep. 30, 2019 | 36,503,800 | | | | |
Ending balance, value at Sep. 30, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,862,522) | $ (110,622) |
Common stock and warrants issued for cash, shares | | | | | |
Common stock and warrants issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | | |
Ending balance, shares at Dec. 31, 2019 | 36,503,800 | | | | |
Ending balance, value at Dec. 31, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,862,522) | $ (110,622) |